219 related articles for article (PubMed ID: 32017901)
1. Dual-targeting liposome modified by glutamic hexapeptide and folic acid for bone metastatic breast cancer.
Yang Y; Zhao Z; Xie C; Zhao Y
Chem Phys Lipids; 2020 May; 228():104882. PubMed ID: 32017901
[TBL] [Abstract][Full Text] [Related]
2. Dual-active targeting liposomes drug delivery system for bone metastatic breast cancer: Synthesis and biological evaluation.
Zhao Z; Zhao Y; Xie C; Chen C; Lin D; Wang S; Lin D; Cui X; Guo Z; Zhou J
Chem Phys Lipids; 2019 Sep; 223():104785. PubMed ID: 31194968
[TBL] [Abstract][Full Text] [Related]
3. Liposomes modified with a multivalent glutamic hexapeptide: A novel and effective way to promote bone targeting.
Zhao Y; Yang Y; Cui Y; Zhao Z; Chen X
Arch Pharm (Weinheim); 2024 Mar; 357(3):e2300620. PubMed ID: 38133558
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and evaluation of liposomes modified with dendritic aspartic acid for bone-specific targeting.
Zhao Z; Chen C; Xie C; Zhao Y
Chem Phys Lipids; 2020 Jan; 226():104832. PubMed ID: 31560875
[TBL] [Abstract][Full Text] [Related]
5. Dual-targeting for brain-specific liposomes drug delivery system: Synthesis and preliminary evaluation.
Peng Y; Zhao Y; Chen Y; Yang Z; Zhang L; Xiao W; Yang J; Guo L; Wu Y
Bioorg Med Chem; 2018 Sep; 26(16):4677-4686. PubMed ID: 30098913
[TBL] [Abstract][Full Text] [Related]
6. Liposomes actively recognizing the glucose transporter GLUT
Fu Q; Zhao Y; Yang Z; Yue Q; Xiao W; Chen Y; Yang Y; Guo L; Wu Y
Arch Pharm (Weinheim); 2019 Feb; 352(2):e1800219. PubMed ID: 30609116
[TBL] [Abstract][Full Text] [Related]
7. Alendronate/folic acid-decorated polymeric nanoparticles for hierarchically targetable chemotherapy against bone metastatic breast cancer.
Chen SH; Liu TI; Chuang CL; Chen HH; Chiang WH; Chiu HC
J Mater Chem B; 2020 May; 8(17):3789-3800. PubMed ID: 32150202
[TBL] [Abstract][Full Text] [Related]
8. RGD peptide conjugated liposomal drug delivery system for enhance therapeutic efficacy in treating bone metastasis from prostate cancer.
Wang F; Chen L; Zhang R; Chen Z; Zhu L
J Control Release; 2014 Dec; 196():222-33. PubMed ID: 25456829
[TBL] [Abstract][Full Text] [Related]
9. Synergistic tumor microenvironment targeting and blood-brain barrier penetration via a pH-responsive dual-ligand strategy for enhanced breast cancer and brain metastasis therapy.
Li M; Shi K; Tang X; Wei J; Cun X; Long Y; Zhang Z; He Q
Nanomedicine; 2018 Aug; 14(6):1833-1843. PubMed ID: 29800759
[TBL] [Abstract][Full Text] [Related]
10. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
[TBL] [Abstract][Full Text] [Related]
11. [Preparation and evaluation of RGD and TAT co-modified paclitaxel loaded liposome].
Gao B; Mu W
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2014 Aug; 39(8):769-74. PubMed ID: 25202944
[TBL] [Abstract][Full Text] [Related]
12. Tyroservatide-TPGS-paclitaxel liposomes: Tyroservatide as a targeting ligand for improving breast cancer treatment.
Jin X; Li M; Yin L; Zhou J; Zhang Z; Lv H
Nanomedicine; 2017 Apr; 13(3):1105-1115. PubMed ID: 27845234
[TBL] [Abstract][Full Text] [Related]
13. Multifunctional Liposomes Enable Active Targeting and Twinfilin 1 Silencing to Reverse Paclitaxel Resistance in Brain Metastatic Breast Cancer.
Du J; Shao Y; Hu Y; Chen Y; Cang J; Chen X; Pei W; Miao F; Shen Y; Muddassir M; Zhang Y; Zhang J; Teng G
ACS Appl Mater Interfaces; 2021 May; 13(20):23396-23409. PubMed ID: 33982563
[TBL] [Abstract][Full Text] [Related]
14. Dual Receptor Targeting Cell Penetrating Peptide Modified Liposome for Glioma and Breast Cancer Postoperative Recurrence Therapy.
Qiu Y; Yu Q; Liu Y; Tang J; Wang X; Lu Z; Xu Z; He Q
Pharm Res; 2018 Apr; 35(7):130. PubMed ID: 29700620
[TBL] [Abstract][Full Text] [Related]
15. Folate receptor targeted delivery of paclitaxel to breast cancer cells via folic acid conjugated graphene oxide grafted methyl acrylate nanocarrier.
Vinothini K; Rajendran NK; Ramu A; Elumalai N; Rajan M
Biomed Pharmacother; 2019 Feb; 110():906-917. PubMed ID: 30572195
[TBL] [Abstract][Full Text] [Related]
16. Development of PEGylated aspartic acid-modified liposome as a bone-targeting carrier for the delivery of paclitaxel and treatment of bone metastasis.
Yamashita S; Katsumi H; Hibino N; Isobe Y; Yagi Y; Tanaka Y; Yamada S; Naito C; Yamamoto A
Biomaterials; 2018 Feb; 154():74-85. PubMed ID: 29120820
[TBL] [Abstract][Full Text] [Related]
17. Berberine and folic acid co-modified pH-sensitive cascade-targeted PTX-liposomes coated with Tween 80 for treating glioma.
Yang C; Yang Z; Wang S; Chen J; Liu Q; Tianle Huang ; Hai L; Lu R; Wu Y
Bioorg Med Chem; 2022 Sep; 69():116893. PubMed ID: 35752143
[TBL] [Abstract][Full Text] [Related]
18. pH-sensitive folic acid and dNP2 peptide dual-modified liposome for enhanced targeted chemotherapy of glioma.
Li M; Shi K; Tang X; Wei J; Cun X; Chen X; Yu Q; Zhang Z; He Q
Eur J Pharm Sci; 2018 Nov; 124():240-248. PubMed ID: 30071282
[TBL] [Abstract][Full Text] [Related]
19. Liposomes modified with double-branched biotin: A novel and effective way to promote breast cancer targeting.
Lu R; Zhou L; Yue Q; Liu Q; Cai X; Xiao W; Hai L; Guo L; Wu Y
Bioorg Med Chem; 2019 Jul; 27(14):3115-3127. PubMed ID: 31155297
[TBL] [Abstract][Full Text] [Related]
20. Biotin and glucose dual-targeting, ligand-modified liposomes promote breast tumor-specific drug delivery.
Huang M; Pu Y; Peng Y; Fu Q; Guo L; Wu Y; Zheng Y
Bioorg Med Chem Lett; 2020 Jun; 30(12):127151. PubMed ID: 32317211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
